Correction to: Annals of Hematology https://doi.org/10.1007/s00277-021-04465-4

Due to an oversight during the preparation of figures for manuscript submission, the numbers of patients at risk were omitted from the bottom of Fig. 1, panel C. These have now been added along the x-axis to ensure that readers have the most complete information regarding the analysis shown.

Fig. 1
figure 1

Kaplan–Meier plots of overall survival in the a overall population, b de novo AML subgroup, c secondary AML subgroup, and d overall population censoring for patients receiving follow-up HMAs. GLAS, glasdegib; mo, months; mOS, median overall survival

The original article has been corrected.